The medical service sector bucked the trend. Berry Genomics and Baihua Pharmaceutical rose and stopped, while Wanbang Pharmaceuticals, Zhaoyan New Pharmaceutical, Puri Ophthalmology, Aoyang Health, and Nanmo Biotech followed suit.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.